-
1
-
-
61549087775
-
Cisplatin: A review of toxicities and therapeutic applications [Review]
-
Barabas, K., Milner, R., Lurie, D., & Adin, C. (2008). Cisplatin: A review of toxicities and therapeutic applications [Review]. V e t e r i-nary and Comparative Oncology, 6(1), 1-18.
-
(2008)
Veterinary and Comparative Oncology
, vol.6
, Issue.1
, pp. 1-18
-
-
Barabas, K.1
Milner, R.2
Lurie, D.3
Adin, C.4
-
2
-
-
0029801241
-
Neuroprotectant drugs in cisplatin neurotoxicity
-
Cavaletti, G., Cascinu, S., Venturino, P., Tedeschi, M., & Tredici, G. (1996). Neuroprotectant drugs in cisplatin neurotoxicity. Anti-cancer Research, 16(5B), 3149-3159.
-
(1996)
Anti-cancer Research
, vol.16
, Issue.B
, pp. 3149-3159
-
-
Cavaletti, G.1
Cascinu, S.2
Venturino, P.3
Tedeschi, M.4
Tredici, G.5
-
3
-
-
8844232619
-
Chemotherapy-induced peripheral neurotoxicity [Review]
-
Cavaletti, G., & Marmiroli, P. (2004). Chemotherapy-induced peripheral neurotoxicity [Review]. Expert Opinion on Drug Safety, 3(6), 535-546.
-
(2004)
Expert Opinion on Drug Safety
, vol.3
, Issue.6
, pp. 535-546
-
-
Cavaletti, G.1
Marmiroli, P.2
-
4
-
-
0018365284
-
Nerve fber conduction velocity distributions. I. Estimation based on the single-fber and compound action potentials
-
Cummins, K. L., Dorfman, L. J., & Perkel, D. H. (1979a). Nerve fber conduction velocity distributions. I. Estimation based on the single-fber and compound action potentials. Electroencephalog-raphy and Clinical Neurophysiology, 46, 634-646.
-
(1979)
Electroencephalog-raphy and Clinical Neurophysiology
, vol.46
, pp. 634-646
-
-
Cummins, K.L.1
Dorfman, L.J.2
Perkel, D.H.3
-
5
-
-
0018420873
-
Nerve fber conduction velocity distribution. II. Estimation based on two compound action potentials
-
Cummins, K. L., Dorfman, L. J., & Perkel, D. H. (1979b). Nerve fber conduction velocity distribution. II. Estimation based on two compound action potentials. Elec-troencephalography and Clinical Neurophysiology, 46, 647-658.
-
(1979)
Electroencephalography and Clinical Neurophysiology
, vol.46
, pp. 647-658
-
-
Cummins, K.L.1
Dorfman, L.J.2
Perkel, D.H.3
-
6
-
-
0036692468
-
Comparison of fber diameter distribution deduced by modelling compound action potentials recorded by extracellular and suction techniques
-
Dalkilic, N., & Pehlivan, F. (2002a). Comparison of fber diameter distribution deduced by modelling compound action potentials recorded by extracellular and suction techniques. International Journal of Neuroscience, 112, 913-930.
-
(2002)
International Journal of Neuroscience
, vol.112
, pp. 913-930
-
-
Dalkilic, N.1
Pehlivan, F.2
-
7
-
-
0036748495
-
A correction procedure for the volume conductor effect in the compound action potential recorded from isolated nerve trunk
-
Dalkilic, N., & Pehlivan F. (2002b). A correction procedure for the volume conductor effect in the compound action potential recorded from isolated nerve trunk. International Journal of Neu-roscience, 112, 1013-1026.
-
(2002)
International Journal of Neuroscience
, vol.112
, pp. 1013-1026
-
-
Dalkilic, N.1
Pehlivan, F.2
-
8
-
-
66149124525
-
Effect of tramadol on the rat sciatic nerve conduction: A numerical analysis and conduction velocity distribution study
-
Dalkilic, N., Tuncer, S., Bariskaner, H., & Kiziltan, E. (2009). Effect of tramadol on the rat sciatic nerve conduction: A numerical analysis and conduction velocity distribution study. Yakugaku Zasshi, 129(4), 485-493.
-
(2009)
Yakugaku Zasshi
, vol.129
, Issue.4
, pp. 485-493
-
-
Dalkilic, N.1
Tuncer, S.2
Bariskaner, H.3
Kiziltan, E.4
-
9
-
-
0003830405
-
-
New York: Raven
-
Delisa, J. A., Lee, H. J., Baran, E. M., Lai, K.-S., & Spielholz, N. (1994). Manual of nerve conduction velocity and clinical neurophys-iology. New York: Raven.
-
(1994)
Manual of Nerve Conduction Velocity and Clinical Neurophysiology
-
-
Delisa, J.A.1
Lee, H.J.2
Baran, E.M.3
Lai, K.-S.4
Spielholz, N.5
-
10
-
-
0018191658
-
Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum (II) treatment: A case report
-
Kedar, A., Cohen, M. E., & Freeman, A. I. (1978). Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum(II) treatment: A case report. Cancer Treatment Reports, 62(5), 819-821.
-
(1978)
Cancer Treatment Reports
, vol.62
, Issue.5
, pp. 819-821
-
-
Kedar, A.1
Cohen, M.E.2
Freeman, A.I.3
-
11
-
-
33846953587
-
Conduction velocity distribution: Early diagnostic tool for peripheral neuropathies
-
Kiziltan, E., Dalkilic, N., Guney, F. B., & Pehlivan, F. (2007). Conduction velocity distribution: Early diagnostic tool for peripheral neuropathies. International Journal of Neuroscience, 117(2), 203-213.
-
(2007)
International Journal of Neuroscience
, vol.117
, Issue.2
, pp. 203-213
-
-
Kiziltan, E.1
Dalkilic, N.2
Guney, F.B.3
Pehlivan, F.4
-
12
-
-
1842425571
-
Compound sensory action potential in normal and pathological human nerve
-
Krarup, C. (2004). Compound sensory action potential in normal and pathological human nerve. Muscle & Nerve, 29, 465-483.
-
(2004)
Muscle & Nerve
, vol.29
, pp. 465-483
-
-
Krarup, C.1
-
13
-
-
12244299440
-
The impact of different antioxi-dant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: Correlation with disease progression
-
Mantovani, G., Maccio, A., Madeddu, C., Mura, L., Gramignano, G., Lusso, M. R., et al. (2003). The impact of different antioxi-dant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: Correlation with disease progression. Free Radical Research, 37, 213-223.
-
(2003)
Free Radical Research
, vol.37
, pp. 213-223
-
-
Mantovani, G.1
MacCio, A.2
Madeddu, C.3
Mura, L.4
Gramignano, G.5
Lusso, M.R.6
-
14
-
-
56349134317
-
Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy
-
Melli, G., Taiana, M., Camozzi, F., Triolo, D., Podini P., Quattrini, A., et al. (2008). Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Experimental Neurology, 214(2), 276-284.
-
(2008)
Experimental Neurology
, vol.214
, Issue.2
, pp. 276-284
-
-
Melli, G.1
Taiana, M.2
Camozzi, F.3
Triolo, D.4
Podini, P.5
Quattrini, A.6
-
15
-
-
0031803334
-
Alpha-Lipoic acid: A metabolic antiaoxidant which regulates NF-kappa B signal transduction and protects against oxidative injury
-
Packer, L. (1998). Alpha-Lipoic acid: A metabolic antiaoxidant which regulates NF-kappa B signal transduction and protects against oxidative injury. Drug Metabolism Reviews, 30(2), 245-275.
-
(1998)
Drug Metabolism Reviews
, vol.30
, Issue.2
, pp. 245-275
-
-
Packer, L.1
-
16
-
-
0032698807
-
Bispectral de-noising of the compound action potential for estimation of the nerve conduction velocity distribution
-
Papadopolulou, F. A., & Panas, S. M. (1999). Bispectral de-noising of the compound action potential for estimation of the nerve conduction velocity distribution. Medical Engineering & Physics, 21, 499-503.
-
(1999)
Medical Engineering & Physics
, vol.21
, pp. 499-503
-
-
Papadopolulou, F.A.1
Panas, S.M.2
-
17
-
-
4444364402
-
-
Ankara, Turkey: Hacettepe-Tas Kitapcilik
-
Pehlivan, F. (1997). Biyofizik [Biophysics]. Ankara, Turkey: Hacettepe-Tas Kitapcilik.
-
(1997)
Biyofizik [Biophysics]
-
-
Pehlivan, F.1
-
19
-
-
0023848869
-
Newer electrodiagnostic techniques in peripheral nerve injuries [Review]
-
Peterson, G. W., & Will, A. D. (1988). Newer electrodiagnostic techniques in peripheral nerve injuries [Review]. Current Opinion in Neurology, 19(1), 13-25.
-
(1988)
Current Opinion in Neurology
, vol.19
, Issue.1
, pp. 13-25
-
-
Peterson, G.W.1
Will, A.D.2
-
20
-
-
0036797512
-
Melatonin: Reducing the toxicity and increasing the effcacy of drugs
-
Reiter, R. J., Tan, D. X., Sainz, R. M., Mayo, J. C., & Lopez-Burillo, S. (2002). Melatonin: Reducing the toxicity and increasing the effcacy of drugs. Journal of Pharmacy and Pharmacology, 54, 1299-1321.
-
(2002)
Journal of Pharmacy and Pharmacology
, vol.54
, pp. 1299-1321
-
-
Reiter, R.J.1
Tan, D.X.2
Sainz, R.M.3
Mayo, J.C.4
Lopez-Burillo, S.5
-
21
-
-
34047252329
-
Relationship between the fring frequency of injured peripheral neurons and inhibition of fring by sodium channel blockers
-
Ritter, A. M., Ritchie, C., & Martin, W. J. (2007). Relationship between the fring frequency of injured peripheral neurons and inhibition of fring by sodium channel blockers. Journal of Pain, 8(4), 287-295.
-
(2007)
Journal of Pain
, vol.8
, Issue.4
, pp. 287-295
-
-
Ritter, A.M.1
Ritchie, C.2
Martin, W.J.3
-
22
-
-
33947212468
-
Mechanisms of cisplatin-induced ototoxicity and prevention
-
Rybak, L. P., Whitworth, C. A., Mukherjea, D., & Ramkumar, V. (2007). Mechanisms of cisplatin-induced ototoxicity and prevention. Hearing Research, 226(1-2), 157-167.
-
(2007)
Hearing Research
, vol.226
, Issue.1-2
, pp. 157-167
-
-
Rybak, L.P.1
Whitworth, C.A.2
Mukherjea, D.3
Ramkumar, V.4
-
23
-
-
0025741127
-
Models and analysis of compound nerve action potentials [Review]
-
Schoonhoven, R., & Stegeman, D. F. (1991). Models and analysis of compound nerve action potentials [Review]. Critical Reviews in Biomedical Engineering, 19(1), 47-111.
-
(1991)
Critical Reviews in Biomedical Engineering
, vol.19
, Issue.1
, pp. 47-111
-
-
Schoonhoven, R.1
Stegeman, D.F.2
-
24
-
-
61449190676
-
Central and peripheral nervous system toxicity of common chemotherapeutic agents
-
Sioka, C., & Kyritsis, A. P. (2009). Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemotherapy and Pharmacology, 63(5), 761-767.
-
(2009)
Cancer Chemotherapy and Pharmacology
, vol.63
, Issue.5
, pp. 761-767
-
-
Sioka, C.1
Kyritsis, A.P.2
-
25
-
-
0034112713
-
Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: Antioxidant defense system
-
Somani, S. M., Husain, K., Whitworth, C., Trammell, G. L., Malafa, M., & Rybak, L. P. (2000). Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: Antioxidant defense system. Pharmacology & Toxicology, 86, 234-241.
-
(2000)
Pharmacology & Toxicology
, vol.86
, pp. 234-241
-
-
Somani, S.M.1
Husain, K.2
Whitworth, C.3
Trammell, G.L.4
Malafa, M.5
Rybak, L.P.6
-
26
-
-
0027482337
-
CMAP dispersion, amplitude decay, and area decay in a normal population
-
Taylor, P. K. (1993). CMAP dispersion, amplitude decay, and area decay in a normal population. Muscle & Nerve, 16, 1181-1187.
-
(1993)
Muscle & Nerve
, vol.16
, pp. 1181-1187
-
-
Taylor, P.K.1
-
27
-
-
33846605481
-
Cisplatin modulates voltage gated channel currents of dorsal root ganglion neurons of rats
-
Tomaszewski, A., & Büsselberg, D. (2007). Cisplatin modulates voltage gated channel currents of dorsal root ganglion neurons of rats. Neurotoxicology, 28(1), 49-58.
-
(2007)
Neurotoxicology
, vol.28
, Issue.1
, pp. 49-58
-
-
Tomaszewski, A.1
Büsselberg, D.2
-
28
-
-
0035860151
-
Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: Time course and prognosis
-
Von Schlippe, M., Fowler, C. J., & Harland, S. J. (2001). Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: Time course and prognosis. British Journal of Cancer, 85(6), 823-826.
-
(2001)
British Journal of Cancer
, vol.85
, Issue.6
, pp. 823-826
-
-
Von Schlippe, M.1
Fowler, C.J.2
Harland, S.J.3
-
29
-
-
73649106583
-
Resveratrol protects against Cisplatin-induced cardiotoxicity by alleviating oxidative damage
-
Wang, J., He, D., Zhang, Q., Han, Y., Jin, S., & Qi, F. (2009). Resvera-trol protects against Cisplatin-induced cardiotoxicity by alleviating oxidative damage. Cancer Biotherapy & Radiopharmaceuticals, 24(6), 675-680.
-
(2009)
Cancer Biotherapy & Radiopharmaceuticals
, vol.24
, Issue.6
, pp. 675-680
-
-
Wang, J.1
He, D.2
Zhang, Q.3
Han, Y.4
Jin, S.5
Qi, F.6
-
30
-
-
0037469914
-
Melatonin prevents the increase in hydroxyl radical-spin trap adduct formation caused by the addition of cis-platin in vitro
-
Yoshida, M., Fukuda, A., Hara, M., Terada, A., Kitanaka, Y., & Owada, S. (2003). Melatonin prevents the increase in hydroxyl radical-spin trap adduct formation caused by the addition of cis-platin in vitro. Life Sciences, 72, 1773-1780.
-
(2003)
Life Sciences
, vol.72
, pp. 1773-1780
-
-
Yoshida, M.1
Fukuda, A.2
Hara, M.3
Terada, A.4
Kitanaka, Y.5
Owada, S.6
|